FDA – Page 69 – Pharma.Tips

System access control failure during data integrity review – data integrity risk and remediation

Investigating System Access Control Failures in Data Integrity Reviews In the pharmaceutical industry, maintaining data integrity is paramount to ensure compliance with rigorous regulatory standards set forth by agencies like…

Inventory control failure during inspection – how to prevent repeat excursions

Understanding and Addressing Inventory Control Failures During Inspections Inventory control failures can significantly disrupt pharmaceutical operations, leading to compliance risks and operational inefficiencies. Ensuring robust inventory management not only affects…

Patch management weaknesses during system operation – data integrity risk and remediation

Addressing Vulnerabilities in Patch Management During System Operation for Enhanced Data Integrity In the pharmaceutical manufacturing landscape, maintaining data integrity is paramount, particularly concerning computerized systems. Frequent patching is critical…

Excursion trend ignored during distribution qualification – regulatory inspection outcome

Investigation of Ignored Excursion Trends During Distribution Qualification and Their Regulatory Implications Pharmaceutical manufacturing and quality professionals often encounter challenges during regulatory inspections, particularly regarding distribution qualifications. One critical area…

CSV not aligned to actual use during inspection walkthrough – data integrity risk and remediation

Challenges of CSV Alignment to Actual Use During Inspection Walkthroughs In the realm of pharmaceutical manufacturing and quality control, a common yet critical issue arises when computer system validation (CSV)…

Supplier change unqualified during distribution qualification – regulatory inspection outcome

Investigation of Unqualified Supplier Change During Distribution Qualification and Its Impact on Regulatory Inspections The integrity of the pharmaceutical supply chain hinges on the rigorous qualification of suppliers throughout distribution.…

Audit trail gaps identified during data integrity review – data integrity risk and remediation

Identifying and Addressing Audit Trail Gaps from Data Integrity Reviews Audit trail gaps identified during data integrity review can severely impact pharmaceutical manufacturing and quality assurance processes. These discrepancies raise…

Distribution temperature breach during distribution qualification – product quality risk assessment

Assessing Risks from Distribution Temperature Breaches in Pharmaceutical Supply Chains In the pharmaceutical industry, distribution temperature breaches can pose significant risks to product quality and integrity during distribution qualification. Such…

Data backup and restore failure during system upgrades – preventing repeat CSV observations

“`html Addressing Data Backup and Restore Failure During System Upgrades for Enhanced Compliance In today’s pharmaceutical manufacturing landscape, maintaining data integrity during system upgrades is crucial. Recently, there have been…

Transport qualification gaps during inspection – documentation pack for auditors

Identifying and Addressing Transport Qualification Gaps During Audits In pharmaceutical manufacturing and distribution, transport qualification is critical for ensuring that products are maintained under specified conditions throughout the supply chain.…

User account governance failures during validation lifecycle – FDA/EMA expectations for computerized systems

Addressing User Account Governance Failures in the Validation Lifecycle: FDA and EMA Standards User account governance failures during the validation lifecycle can lead to significant compliance risks, including data integrity…

Cold chain excursion not assessed during audit – CAPA and system remediation

Investigating Cold Chain Excursions Not Assessed During Audits In the pharmaceutical industry, maintaining the integrity of products during storage and transportation is non-negotiable. Cold chain excursions—deviations from designated temperature ranges—pose…